Sponsor Pipeline

JYAMS PET Research & Development Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Phase 3
2
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT07752784
Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem…		 Enrolling by invitation only
2026-08-13 NCT07752784
Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem…		 date change Primary completion pushed: 2026-12-31 -> 2027-04-30
2026-08-13 NCT07752784
Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem…		 date change Completion pushed: 2027-04-07 -> 2027-08-15
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-07 NCT07752784 Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem… Phase 3 Enrolling by Invitation
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07422857 Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment… Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia Recruiting
NCT07752784 Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem… Alzheimer's Disease Enrolling by Invitation
Disease Areas
Alzheimer's Disease (2) Dementia (1)
Get alerts when JYAMS PET Research & Development Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free